This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Fake medicines tackled by EUIPO, Europol, European Medicines Agency

( January 30, 2025, 11:56 GMT | Official Statement) -- MLex Summary: Three agencies — the EU Intellectual Property Office, Europol and the European Medicines Agency — have launched a campaign on public health concerns stemming from fake medicines. The three agencies said in a press release: “[We] are working together to highlight the devastating consequences of fake medicines, which pose significant health risks to consumers and inflict substantial costs on the EU's health and social care systems.”See the full press release from the EUIPO with video content here....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections